Idenix Pharmaceuticals to Present at Three Upcoming Conferences
01 September 2005 - 11:30PM
PR Newswire (US)
CAMBRIDGE, Mass., Sept. 1 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that
Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief
executive officer, will present a corporate overview at the
upcoming Newsmakers in the Biotech Industry Conference on Friday,
September 9, 2005 at 10:30 a.m. at the Sheraton New York Hotel
& Towers and at the Bear Stearns 18th Annual Healthcare
Conference on Monday, September 12, 2005 at 3:30 p.m. at the Grand
Hyatt New York. David A. Arkowitz, Idenix's chief financial
officer, will present a corporate overview at the ThinkEquity
Partners Growth Conference on Thursday, September 15, 2005 at 10:00
a.m. at The Ritz-Carlton, San Francisco. The live and archived
webcasts of the presentations can be accessed under "Events" in the
Idenix Investor Center at http://www.idenix.com/. The archived
replays will be available on the Idenix website for two weeks
following the presentations. About Idenix: Idenix Pharmaceuticals,
Inc. is a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of
infections caused by hepatitis B virus, hepatitis C virus and human
immunodeficiency virus (HIV). Idenix's headquarters are located in
Cambridge, Massachusetts and it has drug discovery operations in
Montpellier, France and Cagliari, Italy. Contact: Idenix
Pharmaceuticals, Inc. Media: Teri Dahlman (617) 995-9905 Investors:
Amy Sullivan (617) 995-9838 DATASOURCE: Idenix Pharmaceuticals,
Inc. CONTACT: Teri Dahlman, +1-617-995-9905, or Amy Sullivan,
+1-617-995-9838 both of Idenix Pharmaceuticals, Inc. Web site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles